论文部分内容阅读
目的:为完善我国基本药物政策,提高基本药物可负担性提供参考。方法:收集2011年我国17省(区、市)的基本药物中标数据,选用治疗5种常见病的18种基本药物,参考世界卫生组织(WHO)和国际健康行动机构(HAI)对药品可负担性研究的标准方法,实证分析我国基本药物的可负担性情况。结果与结论:我国基本药物可负担性总体状况较好,但不同药品间可负担性差异较大,地区间差距不大,且原研药和仿制药的可负担性也存在一定差距。应大力推广和普及应用《基本药物临床应用指南》和《基本药物处方集》,完善基本药物招标制度,进一步调整原研药价格。
Objective: To provide reference for improving the basic medicine policy in our country and raising the affordability of essential medicines. Methods: To collect the basic medicines of 17 provinces (autonomous regions and municipalities) in our country in 2011 and select 18 kinds of essential medicines to treat 5 kinds of common diseases. With reference to the World Health Organization (WHO) and International Health Action Organization (HAI) The standard method of sexual research, empirical analysis of the affordability of basic drugs in our country. RESULTS AND CONCLUSION: The overall affordability of essential drugs in our country is good, but the affordability of different drugs is quite different, the difference between regions is small, and there is a certain gap between the affordability of original and generic drugs. We should vigorously promote and popularize the Guide to Clinical Applications of Essential Medicines and the Essential Medicines Prescription Set, improve the bidding system for essential medicines and further adjust the prices of the original research medicines.